Centauri Therapeutics Limited: Centauri Therapeutics Closes £24 Million GBP Series A Investment Round
Investment from Boehringer Ingelheim Venture Fund, Evotec SE, and Novo Holdings REPAIR Impact Fund Funding will support continued advancement of Centauri's antimicrobial resistance research
Johannes Zanzinger Mike Westby Sebastian Kreuz Kostenloser Wertpapierhandel Camilla Petrycer Hansen Michelle Ricketts
Source: finanznachrichten.de